O'Neill A - Search Results

1

Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer.

Partridge AH, Sepucha K, O'Neill A, Miller KD, Motley C, Swaby RF, Schneider BP, Dang CT Jr, Northfelt DW, Sledge GW Jr. Partridge AH, et al. JAMA Oncol. 2015 Jun;1(3):369-74. doi: 10.1001/jamaoncol.2015.0246. JAMA Oncol. 2015. PMID: 26114161 Free PMC article. Clinical Trial.

2

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Sparano J, O'Neill A, Alpaugh K, Wolff AC, Northfelt DW, Dang CT, Sledge GW, Miller KD. Sparano J, et al. JAMA Oncol. 2018 Dec 1;4(12):1700-1706. doi: 10.1001/jamaoncol.2018.2574. JAMA Oncol. 2018. PMID: 30054636 Free PMC article. Clinical Trial.

3

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.

Ruddy KJ, O'Neill A, Miller KD, Schneider BP, Baker E, Sparano JA, Dang C, Northfelt DW, Sledge GW Jr, Partridge AH. Ruddy KJ, et al. Breast Cancer Res Treat. 2014 Apr;144(3):591-7. doi: 10.1007/s10549-014-2891-0. Epub 2014 Mar 2. Breast Cancer Res Treat. 2014. PMID: 24584876 Free PMC article. Clinical Trial.

4

Survival benefit needed to undergo chemotherapy: Patient and physician preferences.

Vaz-Luis I, O'Neill A, Sepucha K, Miller KD, Baker E, Dang CT, Northfelt DW, Winer EP, Sledge GW, Schneider B, Partridge AH. Vaz-Luis I, et al. Cancer. 2017 Aug 1;123(15):2821-2828. doi: 10.1002/cncr.30671. Epub 2017 Mar 21. Cancer. 2017. PMID: 28323331 Free PMC article.

5

Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?

Partridge AH, Sepucha K, O'Neill A, Miller KD, Baker E, Dang CT, Northfelt DW, Sledge GW, Schneider BP. Partridge AH, et al. Breast Cancer Res Treat. 2017 Oct;165(3):545-553. doi: 10.1007/s10549-017-4338-x. Epub 2017 Jun 23. Breast Cancer Res Treat. 2017. PMID: 28646344 Free PMC article.

6

Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103).

Miller KD, O'Neill A, Gradishar W, Hobday TJ, Goldstein LJ, Mayer IA, Bloom S, Brufsky AM, Tevaarwerk AJ, Sparano JA, Le-Lindqwister NA, Hendricks CB, Northfelt DW, Dang CT, Sledge GW Jr. Miller KD, et al. J Clin Oncol. 2018 Sep 1;36(25):2621-2629. doi: 10.1200/JCO.2018.79.2028. Epub 2018 Jul 24. J Clin Oncol. 2018. PMID: 30040523 Free PMC article. Clinical Trial.

7

Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer.

Rosenberg SM, O'Neill A, Sepucha K, Miller KD, Dang CT, Northfelt DW, Sledge GW, Schneider BP, Partridge AH. Rosenberg SM, et al. JAMA Netw Open. 2022 Feb 1;5(2):e220254. doi: 10.1001/jamanetworkopen.2022.0254. JAMA Netw Open. 2022. PMID: 35226083 Free PMC article. Clinical Trial.

8

Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198).

Schneider BP, O'Neill A, Shen F, Sledge GW, Thor AD, Kahanic SP, Zander PJ, Davidson NE. Schneider BP, et al. Br J Cancer. 2015 Dec 22;113(12):1651-7. doi: 10.1038/bjc.2015.405. Epub 2015 Dec 1. Br J Cancer. 2015. PMID: 26625004 Free PMC article. Clinical Trial.

9

A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group.

Miller KD, O'Neill A, Perez EA, Seidman AD, Sledge GW. Miller KD, et al. Ann Oncol. 2012 Feb;23(2):331-7. doi: 10.1093/annonc/mdr344. Epub 2011 Aug 4. Ann Oncol. 2012. PMID: 21821545 Free PMC article. Clinical Trial.

10

A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer.

Carlson RW, O'Neill A, Vidaurre T, Gomez HL, Badve SS, Sledge GW. Carlson RW, et al. Breast Cancer Res Treat. 2012 Jun;133(3):1049-56. doi: 10.1007/s10549-012-1997-5. Epub 2012 Mar 15. Breast Cancer Res Treat. 2012. PMID: 22418699 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

993 results

Search Page